Literature DB >> 23375729

Relation of triiodothyronine to subclinical myocardial injury in patients with chest pain.

Bo-Bae Kim1, Yo-Han Ku, Jung-Yeon Han, Jung-Min Ha, Geon Park, Dong-Hyun Choi, Heesang Song.   

Abstract

Heart dysfunctions have been shown to be associated with altered concentrations of thyroid hormones. However, the relation between thyroid hormones and subclinical myocardial injury in those without clinically apparent coronary heart disease is not well-established. We examined the correlation between altered levels of thyrotropin, free thyroxine, and triiodothyronine (T3) and high-sensitivity cardiac troponin T (hs-cTnT) in 250 patients (mean age 60 years; 42% men) with chest pain, who were free of coronary heart disease and heart failure. These patients were examined in the emergency room or outpatient department of the cardiovascular center of Chosun University Hospital. Multivariate logistic regression models were used for statistical analysis. The baseline values of T3 were associated with elevated hs-cTnT levels (r = -0.428, p <0.001), a significantly negative correlation. We did not observe any significant correlation between the thyrotropin or free thyroxine and hs-cTnT levels. When the T3 cutoff was set at 74.6 ng/dl using the receiver operating characteristic curve, the sensitivity and specificity was 70% and 69%, respectively, for differentiating between groups with and without myocardial injury. After adjusting for traditional risk factors, the odds ratio for an elevated hs-cTnT level (≥0.014 ng/ml) for patients with T3 <74.6 ng/dl was 6.95 (95% confidence interval 3.09 to 15.66) compared to patients with T3 ≥74.6 ng/dl. In conclusion, the T3 levels were negatively related to hs-cTnT levels among patients without clinically obvious coronary heart disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23375729     DOI: 10.1016/j.amjcard.2012.12.039

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  N-acetylcysteine administration prevents nonthyroidal illness syndrome in patients with acute myocardial infarction: a randomized clinical trial.

Authors:  Josi Vidart; Simone Magagnin Wajner; Rogério Sarmento Leite; André Manica; Beatriz D Schaan; P Reed Larsen; Ana Luiza Maia
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

2.  Non-thyroidal illness syndrome predicts outcome in adult critically ill patients: a systematic review and meta-analysis.

Authors:  Josi Vidart; Paula Jaskulski; Ana Laura Kunzler; Rafael Aguiar Marschner; André Ferreira de Azeredo da Silva; Simone Magagnin Wajner
Journal:  Endocr Connect       Date:  2022-02-09       Impact factor: 3.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.